INVENTORIES (Tables)

12 Months Ended

Mar. 29, 2025

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of material, labor and manufacturing overhead. Cost is determined with the first-in, first-out method.

(In thousands)	March 29, 2025		March 30, 2024
Raw materials	$	128,574	$	134,150
Work-in-process	14,956		15,488
Finished goods	221,611		167,564
Total inventories	$	365,141	$	317,202

In the fourth quarter of fiscal 2025, the Company completed the divestiture of its Whole Blood product line within its Blood Center business unit and all related assets and liabilities were sold. The inventory related to the divestiture had a value of $26.4 million and has been removed from the Consolidated Balance Sheets.

In fiscal 2024, the Company issued a voluntary recall of certain products within the Whole Blood portion of our Blood Center business unit sold to customers in the U.S. and certain foreign jurisdictions. The Company has recorded charges of $4.4 million related to inventory.